These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17165131)

  • 21. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
    Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
    Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examining the metastatic niche: targeting the microenvironment.
    Guise T
    Semin Oncol; 2010 Oct; 37 Suppl 2():S2-14. PubMed ID: 21111245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-bone interactions in skeletal metastasis.
    Orr FW; Sanchez-Sweatman OH; Kostenuik P; Singh G
    Clin Orthop Relat Res; 1995 Mar; (312):19-33. PubMed ID: 7634602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of skeletal metastases.
    Kitazawa S; Maeda S
    Clin Orthop Relat Res; 1995 Mar; (312):45-50. PubMed ID: 7634617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism and treatment of cancer metastasis to bone].
    Yoneda T
    Clin Calcium; 2005 Jul; 15(7):29-37. PubMed ID: 15995293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravascular cell-to-cell adhesive interactions and bone metastasis.
    Glinsky VV
    Cancer Metastasis Rev; 2006 Dec; 25(4):531-40. PubMed ID: 17171440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone.
    Saha B; Chaiwun B; Imam SS; Tsao-Wei DD; Groshen S; Naritoku WY; Imam SA
    Anticancer Res; 2007; 27(6B):3903-8. PubMed ID: 18225549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial microvascularization and breast cancer colonization in bone.
    Yoneda T
    Histol Histopathol; 1997 Oct; 12(4):1145-9. PubMed ID: 9302573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.
    Chirgwin JM; Guise TA
    J Cell Biochem; 2007 Dec; 102(6):1333-42. PubMed ID: 17907152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future treatment of bone metastases.
    Lipton A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
    Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
    Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms and treatment of bone metastasis.
    Clines GA; Guise TA
    Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can bone markers guide more effective treatment of bone metastases from breast cancer?
    Clemons M; Cole DE; Gainford MC
    Breast Cancer Res Treat; 2006 May; 97(1):81-90. PubMed ID: 16319976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local effects of malignancy on bone.
    Brown SA; Clines GA; Guise TA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.